![John Randle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Randle
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von John Randle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
9
| Extinct | Pharmaceuticals: Other | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John Randle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree | |
Yale University | College/University | Graduate Degree Doctorate Degree | |
The University of Chicago | College/University | Corporate Officer/Principal Undergraduate Degree | |
TARIS BioMedical LLC
![]() TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Translational Development Acquisition Corp.
![]() Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
McGill University | College/University | Undergraduate Degree | |
IDRx, Inc.
![]() IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
OPKO HEALTH, INC. | Medical/Nursing Services | Director/Board Member | |
Modex Therapeutics, Inc.
![]() Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Miscellaneous Commercial Services | Founder | |
TANGO THERAPEUTICS, INC. | Biotechnology | Chairman | |
EQRX, INC. | Pharmaceuticals: Major | Founder | |
Dascena, Inc.
![]() Dascena, Inc. Miscellaneous Commercial ServicesCommercial Services Dascena, Inc. develops machine learning algorithms to enable early disease intervention. The company was founded by Ritankar Das and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member | |
EQRx International, Inc.
![]() EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Thrive Earlier Detection Corp.
![]() Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Celsius Therapeutics, Inc.
![]() Celsius Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Tango Therapeutics Sub, Inc.
![]() Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Museum of Science
![]() Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Chairman | |
RELAY THERAPEUTICS, INC. | Biotechnology | Founder | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Executive Officer | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal | |
Boston Millennia Partners
![]() Boston Millennia Partners Investment ManagersFinance Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Warp Drive Bio, Inc.
![]() Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
National Institute of Child Health & Human Development | General Government | Corporate Officer/Principal | |
Unither Pharmaceuticals LLC
![]() Unither Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Unither Pharmaceuticals LLC produces pharmaceutical supplies. The company is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boston University School of Medicine | College/University | Doctorate Degree | |
BIOVERATIV INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Edimer Pharmaceuticals, Inc.
![]() Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Beth Israel Deaconess Medical Center | Hospital/Nursing Management | Director/Board Member | |
Verseau Therapeutics, Inc.
![]() Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
20/20 HealthCare Partners LLC
![]() 20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Investment Managers | Private Equity Investor | |
Universität Saarbrücken | College/University | Undergraduate Degree | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of New Mexico | College/University | Undergraduate Degree | |
Texas Tech University | College/University | Graduate Degree | |
EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member | |
National Venture Capital Association
![]() National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 48 |
Kanada | 2 |
Schweiz | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 10 |
Commercial Services | 9 |
Finance | 5 |
Health Services | 3 |
Operativ
Director/Board Member | 38 |
Corporate Officer/Principal | 21 |
Chairman | 14 |
Founder | 13 |
Chief Executive Officer | 13 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- John Randle
- Unternehmensverbindungen